Clinical Trials in Minneapolis

Showing 7901-7920 of 11,007 trials

ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest

NCT00189423

The purpose of this study is to determine whether performing active compression decompression cardiopulmonary resuscitation (ACD-CPR) with an impedance threshold device (ITD) compared to conventional standard cardiopulmonary resuscitation (S-CPR) will impact the neurologic recovery and survival to hospital discharge following out-of-hospital cardiac arrest.

Heart ArrestDeath, Sudden, CardiacCardiopulmonary Resuscitation+1 more

Advanced Circulatory Systems1,653 participantsStarted Oct 2005

Indianapolis, Indiana, United States • Ann Arbor, Michigan, United States • Royal Oak, Michigan, United States +4 more locations

COMPLETEDPhase 1/2< 1 mile

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

NCT00093756

This phase I/II trial (phase I closed to accrual as of 09/29/2009) is studying the side effects and best dose of bortezomib, paclitaxel, and carboplatin when given with radiation therapy and to see how well they work in treating patients with stage IIIA or stage IIIB non-small cell lung cancer that cannot be removed by surgery. Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Bortezomib may increase the effectiveness of paclitaxel and carboplatin by making tumor cells more sensitive to the drugs. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving bortezomib, paclitaxel, and carboplatin together with radiation therapy may kill more tumor cells.

Recurrent Non-small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer

National Cancer Institute (NCI)52 participantsStarted Sep 2004

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Jacksonville, Florida, United States +140 more locations

ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

Find Trials by Condition in Minneapolis

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Predictors of Time to Viremia With an Analytic Treatment Interruption

Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Iron Overload in Patients Undergoing Donor Stem Cell Transplant

Vaccination With Tetanus and KLH to Assess Immune Responses.

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Safety and Efficacy Trial of Testosterone Undecanoate

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma